NFKB1 and breast carcinoma: Likewise, studies have demonstrated that DSF/Cu2+ complexes can effectively suppress NF-κB pathway activity and reverse chemoresistance to the antitumor drug gemcitabine in both colon and breast cancer cell lines [41].